MAPK14 and triple-A syndrome: They further demonstrate that similar to MKL1, the lack of MAPK14 in VSMCs reduced the susceptibility to AAA formation and severity in AAA pathology induced by Ang II, at least partially via modulation of vascular inflammation and senescence.